Research Topics
| Thomas GonwaSummaryAffiliation: Mayo Clinic Country: USA Publications
| Collaborators
|
Detail Information
Publications
The challenges of providing renal replacement therapy in decompensated liver cirrhosisThomas A Gonwa
Department of Transplantation, Mayo Clinic in Florida, Jacksonville, FL 32224, USA
Blood Purif 33:144-8. 2012..These are still considered experimental, although the MARS system has been utilized to treat patients with hepatorenal syndrome, and is available outside the United States...- Kidney transplantation after previous liver transplantation: analysis of the organ procurement transplant network databaseThomas A Gonwa
Department of Transplantation, Mayo Clinic, Jacksonville, FL 32224, USA
Transplantation 92:31-5. 2011..Patients after liver transplant have a high incidence of chronic kidney disease and end-stage renal disease (ESRD). We investigated kidney transplantation after liver transplantation using the Organ Procurement Transplant Network database... 
Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us?T A Gonwa
Department of Transplantation, Mayo Clinic Jacksonville, Jacksonville, Florida, USA
Am J Transplant 6:2651-9. 2006..Despite this, patient survival following orthotopic liver transplant (OLTX) in the 34 months after introduction of MELD is not different than prior to introduction of MELD...- Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equationsThomas A Gonwa
Department of Transplantation, Mayo Clinic, Jacksonville, FL 32216, USA
Liver Transpl 10:301-9. 2004..Better methods for estimating the GFR are required for evaluation of renal function before and after liver transplantation... - Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 monthsThomas Gonwa
Mayo Clinic, Jacksonville, FL 32216, USA
Transplantation 75:1213-20. 2003..Results at 6 months of follow-up are presented... - Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine eliminationThomas A Gonwa
Baylor University Medical Center, Dallas, TX, USA
Transplantation 74:1560-7. 2002..This study evaluated whether renal function could be improved by elimination of CsA from an SRL-based regimen... - Immunosuppression for delayed or slow graft function in primary cadaveric renal transplantation: use of low dose tacrolimus therapy with post-operative administration of anti-CD25 monoclonal antibodyThomas A Gonwa
Baylor Institute of Transplantation Sciences, Baylor University Medical Center, Dallas, Texas, USA
Clin Transplant 16:144-9. 2002..The purpose of this study was to evaluate the efficacy of the anti-CD25 monoclonal antibody basiliximab (BSLIX) started post-operatively in patients at high risk for DGF combined with low dose tacrolimus (TAC)... - End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatmentT A Gonwa
Baylor Institute for Transplant Sciences, Baylor University Medical Center, Dallas, Texas, USA
Transplantation 72:1934-9. 2001..This retrospective study examines the incidence and treatment of ESRD and chronic renal failure (CRF) in OLTX patients... - Hypertension and renal dysfunction in long-term liver transplant recipientsT A Gonwa
Renal and Pancreas Transplant, Mayo Clinic Transplant Center, Jacksonville, FL 32216, USA
Liver Transpl 7:S22-6. 2001..4. Hypertension occurs in greater than 50% of long-term survivors. 5. Immunosuppressive protocols must be adjusted early to avoid long-term complications... - Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three yearsThomas Gonwa
Mayo Clinic Transplant Center, 4205 Belfort Blvd, Suite 1100, Jacksonville, FL, 32216, USA
Transplantation 75:2048-53. 2003..In patients who experienced DGF, graft survival was better at 3 years in those patients receiving TAC in combination with either MMF or AZA as compared with the patients receiving CsA with MMF... - Kidney allocation to liver transplant candidates with renal failure of undetermined etiology: role of percutaneous renal biopsyH M Wadei
Department of Transplantation, Mayo Clinic and Foundation, Jacksonville, FL, USA
Am J Transplant 8:2618-26. 2008..Randomized studies are needed to determine if PRB can direct kidney allocation in this challenging group of liver transplant candidates... - Renal replacement therapy and orthotopic liver transplantation: the role of continuous veno-venous hemodialysisT A Gonwa
Baylor Institute of Transplant Sciences, Baylor University Medical Center, 3500 Gaston Avenue, Dallas, TX 75204, USA
Transplantation 71:1424-8. 2001..We have examined our patient population to determine the effect of necessity and type of RRT on patient survival after OLTX... - Readmission to the intensive care unit after liver transplantationM F Levy
Department of Transplant Services, Baylor University Medical Center, Dallas, TX 75246 2096, USA
Crit Care Med 29:18-24. 2001..Patients who, after liver transplantation, fail discharge from the Intensive Care Unit (ICU) and must be readmitted to that unit may well utilize many more resources than those patients who are well enough to stay out of the ICU... - The long-term management of pancreas transplantationMartin L Mai
Department of Transplantation, Mayo Clinic, Jacksonville, FL 32216, USA
Transplantation 82:991-1003. 2006..3 million accounting for 60% of ESRD population. To date, DM is the leading indication for transplantation and is the cause of ESRD in more than 40% of all transplant recipients each year... 
The elderly liver transplant recipient: a call for cautionM F Levy
Baylor University Medical Center, Transplantation Services, Dallas, Texas 75246, USA
Ann Surg 233:107-13. 2001..To determine whether liver transplantation is judicious in recipients older than 60 years of age...- TransplantationT A Gonwa
Transplant Services, Baylor University Medical Center, Dallas, TX 75246, USA
Am J Kidney Dis 35:S153-9. 2000..This paper reviews the major ethical and social problems that still need to be addressed in regards to transplantation. These include organ supply, organ distribution, access to care, funding, and xenotransplantation... - Cannulation of the aorta in organ donors with infrarenal aortic pathologiesE P Molmenti
Baylor University Medical Center, Dallas, Texas 75246, USA
Dig Dis Sci 46:2457-9. 2001..This technique allows for perfusion with UW solution without having to cannulate through severely atherosclerotic distal aortic walls... - Liver allotransplantation after extracorporeal hepatic support with transgenic (hCD55/hCD59) porcine livers: clinical results and lack of pig-to-human transmission of the porcine endogenous retrovirusM F Levy
Transplantation Services, Baylor University Medical Center, Dallas, Texas 75246, USA
Transplantation 69:272-80. 2000..Whole organ extracorporeal perfusion of a genetically modified humanized (transgenic) pig liver has been proposed as a technology that may sustain patients with severe liver failure while awaiting human liver transplantation... - Polymicrobial seminal vesical abscess in a kidney transplant recipientHani M Wadei
Department of Transplantation, Mayo Clinic College of Medicine, Jacksonville, Florida 32216, USA
Urology 72:296. 2008..Here we report a polymicrobial seminal vesicle abscess in a kidney transplant recipient that was not associated with any of the known precipitating events... - Review of major clinical trials with mycophenolate mofetil in renal transplantationGaetano Ciancio
Department of Surgery, Division of Transplantation, Lillian Jean Kaplan Renal Transplant Center, Leonard M Miller School of Medicine, University of Miami, Miami, FL 33101, USA
Transplantation 80:S191-200. 2005.... - Chronic renal failure after transplantation of a nonrenal organThomas A Gonwa
N Engl J Med 349:2563-5; author reply 2563-5. 2003 - Identification of patients best suited for combined liver-kidney transplantation: part IIConnie L Davis
Department of Medicine, Division of Nephrology, University of Washington, Seattle, WA 98195, USA
Liver Transpl 8:193-211. 2002.... - De novo tumors after liver transplantation: a single-institution experienceEdmund Q Sanchez
Transplantation Services, Baylor University Medical Center, Dallas, TX 75246, USA
Liver Transpl 8:285-91. 2002..The risk for development was not enough to preclude transplantation. We found that tumors developed in chronological fashion. Therefore, directed surveillance, patient education, and early detection may facilitate earlier treatment... - Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipientsErnesto P Molmenti
Transplantation Services, Baylor University Medical Center, Dallas, TX 75246, USA
Liver Transpl 8:519-26. 2002..We cannot establish with certainty whether the observed process represents recurrence of the original autoimmune disease, an alloimmune phenomenon, or allograft dysfunction mimicking AIH... - Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I studyBarry D Kahan
Department of Surgery, University of Texas Health Science Center at Houston, Houston, TX, USA
Transplantation 76:1079-84. 2003..This study examined the safety, pharmacodynamics, and pharmacokinetics of multiple doses of FTY720 in stable renal transplant patients... - Combined kidney liver transplant in the MELD era: where are we going?Thomas A Gonwa
Liver Transpl 11:1022-5. 2005 - Hepatorenal syndrome: pathophysiology and managementHani M Wadei
Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, Jacksonville, FL 32216, USA
Clin J Am Soc Nephrol 1:1066-79. 2006 - Preoperative and perioperative predictors of the need for renal replacement therapy after orthotopic liver transplantationEdmund Q Sanchez
Baylor Regional Transplant Institute, Dallas, Texas 75204, USA
Transplantation 78:1048-54. 2004..Our center has previously reported a 1-year survival of only 41.8%. We undertook this study to determine whether we could identify preoperative and perioperative factors that would predict which patients are at risk... - Correlation between intraoperative blood flows and hepatic artery strictures in liver transplantationErnesto P Molmenti
Transplantation Services, Baylor University Medical Center, Dallas, TX 75246, USA
Liver Transpl 8:160-3. 2002..In our series, there was a 6.2% incidence of postoperative HASs. We observed a significant association between intraoperative hepatic artery and portal vein flows and postoperative HASs... - Pathophysiology of renal disease associated with liver disorders: implications for liver transplantation. Part IConnie L Davis
Department of Medicine, Division of Nephrology, University of Washington, Seattle, WA 98195, USA
Liver Transpl 8:91-109. 2002.... - Thrombendvenectomy for organized portal vein thrombosis at the time of liver transplantationErnesto P Molmenti
Baylor University Medical Center, Dallas, Texas 75246, USA
Ann Surg 235:292-6. 2002..It is the authors' procedure of choice in cases of organized PVT at the time of transplantation. Operative time and length of stay in the intensive care unit are not prolonged, and patient and graft survival rates are not compromised...